Are Coles shares a buy ahead of the company's November AGM?

Coles could be in for an exciting few weeks, with a top broker reportedly expecting big things.

| More on:
A man sits in a shopping trolley and shouts buy through a megaphone.

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Key points

  • The Coles share price has been outperforming this year, falling just 8.7% year to date to trade at $$16.38 today
  • Meanwhile, Macquarie is said to be bullish on the stock, slapping it with an outperform rating
  • On top of that, the broker is reportedly expecting big things to come from the company's AGM

Coles Group Ltd (ASX: COL) shares have reportedly been tipped as a November winner, with the company's annual general meeting (AGM) expected to deliver a bout of positivity.

The S&P/ASX 200 Index (ASX: XJO) supermarket operator will host its AGM next month. There, it could provide an update on its activities through the first few months of financial year 2023.

The Coles share price is trading at $16.38 right now, 0.18% higher than its previous close. Meanwhile, the ASX 200 is up 0.23%.

The stock has been outperforming this year so far, falling 8.5% compared to the index's 12.2% tumble.

Let's take a closer look at what the market might be expecting to hear from Coles next month.

Could Coles shares be an AGM winner?

There could be an exciting few weeks ahead for Coles shares. The company is preparing to release its sales results for the first quarter on 26 October and host its AGM on 9 November.  

Making the near future more exciting, Macquarie has reportedly tipped the supermarket operator to be an AGM winner.

The broker has an outperform rating on Coles shares. It expects the company could benefit from an update at its AGM, the Australian Financial Review reports.

Last November, the company's leaders revisited its pandemic-induced struggles before looking to the future, with a focus on the Christmas period.

This time around, they might look back at a period defined by the rising cost of living, inflation, and rate hikes.

Of course, being an S&P/ASX 200 Consumer Staple Index (ASX: XSJ) share, Coles is largely protected from such happenings.

Though, the company noted inflation will still likely impact its bottom line this financial year. Additionally, its sales growth could be dinted from the cycling of 2021 lockdowns.

Management could also look to a future without Coles Express. The business is set to be sold to Viva Energy Group Ltd (ASX: VEA) for $300 million.

Getting down to business, Coles' AGM will see shareholders voting on the election of Terry Bowen and Scott Price onto the company's board.

Meanwhile, Jacqueline Chow and chair James Graham will be standing for re-election. Graham noted that, if re-elected, he will likely retire before the end of the ensuing term.

Macquarie isn't alone in expecting big things from Coles shares in the future. Morgans and Citi both also rate the stock a buy, slapping Coles shares with respective price targets of $20 and $20.10.

Citigroup is an advertising partner of The Ascent, a Motley Fool company. Motley Fool contributor Brooke Cooper has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has positions in and has recommended COLESGROUP DEF SET. The Motley Fool Australia has recommended Macquarie Group Limited. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Consumer Staples & Discretionary Shares

Beef cattle in stockyard.
Consumer Staples & Discretionary Shares

Queensland floods to have a 'material' impact on this ASX agricultural stock's earnings

This company is likely to experience a material hit to earnings as a result of the floods in Queensland.

Read more »

A wine technician in overalls holds a glass of red wine up to the light and studies it.
Consumer Staples & Discretionary Shares

Treasury Wine shares keep the good times flowing

Brokers warn that the current lift is likely to be fragile.

Read more »

A man pushes a supermarket trolley with phone in hand down a supermarket aisle looking at the products on the shelves.
Consumer Staples & Discretionary Shares

Are Coles or Woolworths shares a better buy in 2026?

Which supermarket giant is the better buy this year?

Read more »

Young fruit picker clipping bunch of grapes in vineyard.
Consumer Staples & Discretionary Shares

Down over 50%, is this the ASX 200's greatest recovery share for 2026?

After a brutal year, Treasury Wine shares have been deeply sold off. Is a recovery starting to take shape for…

Read more »

A car dealer stands amid a selection of cars parked in a showroom.
Consumer Staples & Discretionary Shares

This ASX All Ords stock edges lower as investors digest key milestone

After completing a major acquisition, this ASX All Ords stock is back in focus as investors assess the next phase.

Read more »

A little boy surrounded by green grass and trees looks up at the sky, waiting for rain or sunshine.
Consumer Staples & Discretionary Shares

Why is Cobram Estate rocketing 17% today?

Cobram Estate shares jump 17% today after a broker upgrade and renewed confidence in its US growth plans.

Read more »

A young farnmer raise his arms to the sky as he stands in a lush field of wheat or farmland.
Consumer Staples & Discretionary Shares

These agricultural stocks are fundamentally undervalued, Bell Potter says

Bell Potter has named three stocks in the agricultural sector that it believes to be fundamentally undervalued.

Read more »

A baby's eyes open wide in surprise as it sucks on a milk bottle.
Consumer Staples & Discretionary Shares

Why this ASX small-cap share is back in focus after a US market update

A fresh US update has put Bubs shares back on investors’ radars as FDA approval moves closer and sales continue.

Read more »